Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, MBX Biosciences Inc increased its cash reserves by 26.08%, or 6.31m. Cash Flow from Financing totalled 69.22m or -- of revenues. In addition the company used 31.98m for operations while cash used for investing totalled 30.93m.
Cash flow per share | -1.47 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.71 |
---|---|
Tangible book value per share | 1.71 |
More ▼
Balance sheet in USDView more
Current ratio | 7.17 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼